Skip to main content
OncoTargets and Therapy logoLink to OncoTargets and Therapy
. 2023 Jul 19;16:615–616. doi: 10.2147/OTT.S430432

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction]

PMCID: PMC10363395  PMID: 37489157

Wang J, Gao J, Chen Q, et al. Onco Targets Ther. 2020;13:9333–9347.

At the authors request, we the Editor and Publisher of OncoTargets and Therapy are retracting the published article. Concerns were raised to the authors attention regarding the duplication of images in Figures 2 and 5. Specifically,

  • Images from Figure 2E, Invasion, si-LINC1116 1# and si-LINC01116 2#, were duplicated.

  • Images from Figure 5E, Migration, Empty vector and Invasion, Empty vector and pcDNA-LINC0116 were duplicated.

The authors explained that errors had been made during the preparation of the figures, but no original data was provided to the journal. As verifying the validity of published work is core to the integrity of the scholarly record, the authors requested to retract the article. The editor agreed with this decision.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


Articles from OncoTargets and Therapy are provided here courtesy of Dove Press

RESOURCES